Difference between revisions of "Part:BBa K2748000"
Line 24: | Line 24: | ||
In iGEM 2018, SYSU-CHINA attempted to develop a reversible safe switch for CAR T therapy based on the tet-inducible CMV promoter and U24 protein of Human Herpesvirus 6. Since it is the major part of our project, we conducted extensive research on U24 and obtained valuable results.. | In iGEM 2018, SYSU-CHINA attempted to develop a reversible safe switch for CAR T therapy based on the tet-inducible CMV promoter and U24 protein of Human Herpesvirus 6. Since it is the major part of our project, we conducted extensive research on U24 and obtained valuable results.. | ||
− | [[File:SYSU-CHINA parts FLUO+WB.png| | + | In order to determine the optimal concentration of dox for induction, we collected and analyzed fluorescence data and performed western blot analysis. |
+ | |||
+ | Interestingly, although the predicted molecular weight of U24 protein is approximately 10kDa, two bands were detected at 20kDa, consistent with previous research '''(Sullivan and Coscoy, 2010)'''. This suggested that U24 undergoes extensive post-translational modifications. However, the types and functions of these modifications remain unknown. | ||
+ | |||
+ | [[File:SYSU-CHINA parts FLUO+WB.png|800px|thumb|left|'''Figure 2:''' Fluorescence and western blot analysis of U24 expression under different concentration of doxycycline]] | ||
<br style="clear: both" /> | <br style="clear: both" /> | ||
− | + | In order to determine the expression time course after adding dox, equal amount of HEK293T cells were seeded in a 6-well plate and transfected with ptetON-GFP-T2A-U24. Dox was added at the same time in all wells and equal number of cells in each well were harvested at the indicated time for western blot analysis. The result was analyzed with ImageJ and the amount of protein of interest was normalized using β-actin as internal controls. | |
− | [[File:SYSU-CHINA | + | [[File:SYSU-CHINA parts time course.png|500px|thumb|left|'''Figure 3:''' Time course of U24 expression]] |
<br style="clear: both" /> | <br style="clear: both" /> | ||
− | + | In order to determine the degradation rate of U24, equal amount of HEK293T cells were seeded in a 6-well plate and transfected with ptetON-GFP-T2A-U24. Dox was added at the same time in all wells and cycloheximide (CHX), a protein synthesis inhibitor, was added to each well 24h post transfection. Equal number of cells in each well were harvested at indicated time pointe for western blot analysis. The result was analyzed with ImageJ and the amount of protein of interest was normalized using β-actin as internal controls. | |
− | [[File:SYSU-CHINA | + | [[File:SYSU-CHINA parts degradation of U24.png|500px|thumb|left|'''Figure 4:''' Degradation curve of U24]] |
<br style="clear: both" /> | <br style="clear: both" /> | ||
Revision as of 17:57, 17 October 2018
U24 protein from human herpesvirus 6A
U24 protein from human herpesvirus 6A is a C-terminal membrane anchored protein that can downregulate T cell receptors via endosomal recycling inhibition.
Usage and Biology
U24 is a small (87aa) tail-anchored protein(Sullivan and Coscoy, 2010) that can downregulate TCR/CD3 complex from the cell surface by exclusion of CD3 from Rab11-containing recycling endosomes and thus inhibiting TCR complex recycling back to the surface(Sullivan and Coscoy, 2008). While it was demonstrated later that U24 also downregulate transferrin(Sullivan and Coscoy, 2010), its action is relatively specific, without affecting the surface level of ICAM-1, MHC class I, ULBP1, ULBP2, CD4 and CD8(Sullivan and Coscoy, 2008). Since U24 does not colocalized with CD3, it is believed that the downregulation does not rely on the interaction of U24 with CD3 but instead results from interaction of U24 and the endosomal recycling machinery(Sullivan and Coscoy, 2010). In addition, unlike proteins from other herpesviruses that downregulate TCRs or B cell receptors (BCRs), U24 does not activate lymphocyte signaling pathways(Sullivan and Coscoy, 2008). Furthermore, it was demonstrated that U24 can impair T cell activation by antigen presenting cells(Sullivan and Coscoy, 2008).
Design Considerations
The nucleotide sequence of U24 coding sequence was retrieved from NCBI nucleotide database(NCBI Reference Sequence: NM_002006.4:465-932), and synthesized by IGE Biotechnology LTD. Biobrick prefix and suffix was added by PCR using the following primers,
U24-prefix: 5’ cggaattcgcggccgcttctagATGGATCCCCCTCGGACGC 3’
U24-suffix: 5’ AActgcagcggccgctactagtaTCATCGCCTTTGACGATTCACAT 3’
and ligated onto the pSB1C3 plasmid backbone obtained from digestion of pSB1C3-lacI-RFP(Part:BBa_J04450). The sequence was comfirmed by Sanger sequencing by IGE Biotechnology LTD using VF2 as the forward primer.
Note that this part comes in the absence of the stop codon at the end of the sequence, hence this part should be cloned into vectors with pre-existing stop codon, fused with other protein with stop codon, or added a stop codon using PCR prior to use.
Results
For more details, please check out our [http://2018.igem.org/Team:SYSU-CHINA#/Demonstrate result page]!
In iGEM 2018, SYSU-CHINA attempted to develop a reversible safe switch for CAR T therapy based on the tet-inducible CMV promoter and U24 protein of Human Herpesvirus 6. Since it is the major part of our project, we conducted extensive research on U24 and obtained valuable results..
In order to determine the optimal concentration of dox for induction, we collected and analyzed fluorescence data and performed western blot analysis.
Interestingly, although the predicted molecular weight of U24 protein is approximately 10kDa, two bands were detected at 20kDa, consistent with previous research (Sullivan and Coscoy, 2010). This suggested that U24 undergoes extensive post-translational modifications. However, the types and functions of these modifications remain unknown.
In order to determine the expression time course after adding dox, equal amount of HEK293T cells were seeded in a 6-well plate and transfected with ptetON-GFP-T2A-U24. Dox was added at the same time in all wells and equal number of cells in each well were harvested at the indicated time for western blot analysis. The result was analyzed with ImageJ and the amount of protein of interest was normalized using β-actin as internal controls.
In order to determine the degradation rate of U24, equal amount of HEK293T cells were seeded in a 6-well plate and transfected with ptetON-GFP-T2A-U24. Dox was added at the same time in all wells and cycloheximide (CHX), a protein synthesis inhibitor, was added to each well 24h post transfection. Equal number of cells in each well were harvested at indicated time pointe for western blot analysis. The result was analyzed with ImageJ and the amount of protein of interest was normalized using β-actin as internal controls.
References
Sullivan, B.M., and Coscoy, L. (2008). Downregulation of the T-cell receptor complex and impairment of T-cell activation by human herpesvirus 6 u24 protein. Journal of virology 82, 602-608.
Sullivan, B.M., and Coscoy, L. (2010). The U24 protein from human herpesvirus 6 and 7 affects endocytic recycling. Journal of virology 84, 1265-1275.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21INCOMPATIBLE WITH RFC[21]Illegal BamHI site found at 3
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]